What you need to know about today’s top cardiovascular trials in five minutes flat. Join theheart.org direct from the convention hall for brief interviews with the principal investigators
…
continue reading
Cardiovascular Trials Podcasts
Mayo Clinic in collaboration with theheart.org brings you context to the latest news, trials, and trends in cardiovascular medicine. .
…
continue reading
What you need to know about today’s top cardiovascular trials in five minutes flat. Join Dr C Michael Gibson for brief interviews with the principal investigators
…
continue reading
The Heart Podcast is your go-to source for the latest insights and developments in cardiovascular medicine. Each episode features in-depth interviews with renowned authors and leading experts in the field, delving into the latest advances in cardiovascular research and treatments. Heart - heart.bmj.com - is a renowned international journal from the BMJ Group and the British Cardiovascular Society (BCS) dedicated to publishing research and reviews on cardiovascular disease. Stay ahead in your ...
…
continue reading
On Advances in Care, epidemiologist and science communicator Erin Welsh sits down with physicians from NewYork-Presbyterian hospital to discuss the details behind cutting-edge research and innovative treatments that are changing the course of medicine. From breakthroughs in genome sequencing to the backstories on life-saving cardiac procedures, the work of these doctors from Columbia & Weill Cornell Medicine is united by a collective mission to shape the future of health care and transform t ...
…
continue reading
Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epide ...
…
continue reading
Welcome to the MedEvidence! podcast, hosted by Dr. Michael Koren. MedEvidence, where we help you navigate the real truth behind medical research with both a clinical and research perspective. In this podcast, we will discuss with physicians with extensive experience in patient care and research. How do you know that something works? In medicine, we conduct clinical trials to see if things work! Now, let's get to the Truth Behind the Data. Contact us at www.MedEvidence.com
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
“Got Knowledge Doc” Podkast with Dr. RR Baliga The "Got Knowledge Doc" Podkast, hosted by Dr. Ragavendra R. Baliga, is a knowledge-driven platform designed for physicians and healthcare providers seeking to stay at the forefront of medical science and innovation. With a distinguished career in cardiovascular medicine and academic leadership, Dr. Baliga engages with leading experts to explore cutting-edge research, emerging technologies, and transformative insights in medicine and beyond. Eac ...
…
continue reading
Start every other Monday morning (or whenever you listen) with some coffee and cardiology. Dr. Jim Kirkpatrick and John Michael host the University of Washington Medicine Heart Institute faculty for discussions around their passions in the clinic and outside of it. If you would like to contact any guests or for follow-up information please contact [email protected].
…
continue reading
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.
…
continue reading
Diabetes Care “On Air” is the monthly podcast of the American Diabetes Association’s premier clinical research journal, Diabetes Care. In each episode, co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, interview key authors of editor-selected feature articles and discuss the latest research presented in Diabetes Care. The podcast is intended for diabetes researchers and specialists, endocrinologists, and other health care professionals. Join Alice and Mike as they explore the lat ...
…
continue reading
A Cleveland Clinic podcast to help you learn more about heart and vascular disease and conditions affecting your chest. We explore prevention, diagnostic tests, medical and surgical treatments, new innovations and more.
…
continue reading
Lively, roundtable debates covering cardiovascular clinical trials, with host Roxana Mehran, chief scientific officer of the CRF Clinical Trials Center and professor of medicine at Mount Sinai School of Medicine in New York.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Welcome to The Dr. Hyman Show, the groundbreaking podcast redefining health in America and empowering you to take ownership of your health. Hosted by Dr. Mark Hyman—this show tackles the most pressing issues of our time: chronic disease, mental health, food policy and controversy, prevention and recovery, and longevity. In an era where our food system fuels disease and outdated healthcare models fail to address root causes, Dr. Hyman delivers evidence-based insights and expert interviews to ...
…
continue reading
Investigating Innovative Cardiovascular Research at the Intersection of Academic Theory and Clinical Practice. In these discussions we take a deep dive into the latest research and how it informs current practice. For a patient level discussion, please listen to PATIENT PULSE. Available on Apple Podcasts, Spotify, YouTube and most other services. Subscribe to have new podcasts sent directly to your player and please email us with any comments. We would love to hear from you.
…
continue reading
A summary of new trial data, guideline recommendations and expert opinion across diabetes care, run by Diabetes Knowledge into Practice (https://diabetes.knowledgeintopractice.com), featuring interviews with leading experts from across the globe. This podcast is intended for healthcare professionals only. Funding information is available in each episode's notes.
…
continue reading
Open Heart is an online-only, open access cardiology journal dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Its goal is to ensure maximum transparency and maximum impact on research progress and patient care. The journal is published by BMJ in partnership with the British Cardiovascular Society. Open Heart aims to operate a fast submission and review process with continuous publication online, to ensur ...
…
continue reading
At Patient Pulse, we aim to improve understanding of difficult topics in cardiology and medicine. Easy enough for the layman, but detailed enough for someone who wants to know more about their condition or that of a loved one. Available on Apple Podcasts, Spotify, YouTube and most other services. Subscribe to have new podcasts sent directly to your player and please email us with any comments. We would love to hear from you.
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading

1
Strategies to increase female participation in cardiovascular clinical trials
29:04
29:04
Play later
Play later
Lists
Like
Liked
29:04In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Vijay Kunadian from the University of Newcastle and Sarah Brown, a patient with heart disease, who are both co-authors on a consensus statement. They discuss the state of research participation among females in each area of cardiovascular diseas…
…
continue reading

1
S1 Ep179: Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting
12:00
12:00
Play later
Play later
Lists
Like
Liked
12:00At the Society of Hematologic Oncology 2025 Annual Meeting, CancerNetwork® spoke with a variety of experts about notable clinical developments and trial results across the hematologic oncology landscape. Throughout the meeting, clinicians and researchers discussed the latest data and initiatives in myelofibrosis, multiple myeloma, lymphoma, and oth…
…
continue reading

1
From Chemical Imbalance to Metabolic Breakthrough: A New Path for Mental Health
1:17:04
1:17:04
Play later
Play later
Lists
Like
Liked
1:17:04Many psychiatric labels—like bipolar disorder and schizophrenia—can obscure underlying biology, and symptom checklists often fail to explain or heal what’s really going on. Emerging evidence reframes mental illness as a problem of brain energy, mitochondria, and inflammation—shaped by insulin signaling, circadian rhythm disruption, the gut–brain ax…
…
continue reading

1
#364 – AMA #75: Diets: how to evaluate and implement any diet including keto, carnivore, vegan, Mediterranean, and more
13:29
13:29
Play later
Play later
Lists
Like
Liked
13:29View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter explores how to determine the right diet for yourself rather than searching for a universal “best” diet. He begins by laying out five non-negotiable criteria that any sust…
…
continue reading

1
Listener Q&A special: expert insights on CLL, myeloma, and lymphoma
29:19
29:19
Play later
Play later
Lists
Like
Liked
29:19Welcome to the first episode of our Blood Cancer Awareness Month special on VJHemOnc. In this podcast, leading experts answer your most pressing questions on blood cancers. Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, discusses chronic lymphocytic leukemia (CLL), followed by Rakesh Popat, MBBS, MRCP, FRCPath, PhD, Universit…
…
continue reading

1
Part 2: Innovating These NYC Emergency Departments to Address the Mental Health Epidemic
17:46
17:46
Play later
Play later
Lists
Like
Liked
17:46On this episode of Advances in Care, we return to the high-intensity environment of New York City’s emergency departments with Dr. Angela Mills and Dr. Brenna Farmer. Host Erin Welsh hears from these leaders at NewYork-Presbyterian about how they are implementing innovative strategies to meet the challenges of the behavioral health emergencies epid…
…
continue reading

1
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
17:34
17:34
Play later
Play later
Lists
Like
Liked
17:34Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD. Related Content: Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure…
…
continue reading

1
From Drug Smuggler to Healer: How Nick Brewer Created Primal Moves
1:02:10
1:02:10
Play later
Play later
Lists
Like
Liked
1:02:10On this episode of The Dr. Hyman Show, I sit down with Nick Brewer, founder of Primal Moves—a method born from his own healing journey. Once a pro skier turned drug smuggler, he spent ten years in prison, including four in solitary, where he discovered the power of breath and movement to rebuild his body and mind.I had the chance to try Nick’s clas…
…
continue reading
Send us a text Join Cardiologist Dr. Michael Koren as he speaks in front of a live audience to break down the truth about triglycerides. Triglycerides are a type of fat in our blood that acts as an energy source for the body, but high levels can have serious impacts on your heart and health. Dr. Koren explains what triglycerides are, what they do i…
…
continue reading
Kenneth McCurry, MD, and Marie Budev, DO, from Cleveland Clinic’s Lung and Heart-Lung Transplant Program discuss how their multidisciplinary team manages lung failure and advances transplant care. Learn about techniques like ex vivo lung perfusion (EVLP) and ECMO bridging, and how Cleveland Clinic is expanding access to transplantation for complex …
…
continue reading

1
Change in body weight, cardiovascular disease and mortality
21:48
21:48
Play later
Play later
Lists
Like
Liked
21:48In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Carl Lavie from New Orleans, USA. They discuss his editorial on a paper by Zhang and colleagues, which examined associations between changes in body weight, future cardiovascular events and all-cause mortality. They also discuss the state of play with …
…
continue reading
Send us a text Dr. Michael Koren joins Kevin Geddings to discuss the importance of taking reasonable precautions for health and safety. He recounts his experience at a recent Jacksonville Jaguars football game, which was delayed out of an abundance of caution due to a lightning storm. Dr. Koren explains that although the delay was annoying and disr…
…
continue reading

1
S1 Ep178: Cardiovascular Considerations in Breast Cancer Treatment and Survivorship
20:49
20:49
Play later
Play later
Lists
Like
Liked
20:49In this episode, CancerNetwork® spoke with Joseph S. Wallins, MD, MPH, cardiology fellow at Weill Cornell Medicine, about a review of cardiotoxicities associated with breast cancer treatment he coauthored in the June 2025 issue of ONCOLOGY® titled, “Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment.” T…
…
continue reading

1
The Silent Fire Behind Chronic Disease—and How to Put It Out
45:26
45:26
Play later
Play later
Lists
Like
Liked
45:26Inflammation is the body’s natural way of healing, but when it becomes chronic and hidden, it quietly drives many of today’s most common health problems—heart disease, diabetes, dementia, cancer, autoimmune conditions, and more. Unlike the redness and swelling from a cut or sprain, this “silent inflammation” often goes unnoticed while slowly damagi…
…
continue reading

1
#363 ‒ A new frontier in neurosurgery: restoring brain function with brain-computer interfaces, advancing glioblastoma care, and new hope for devastating brain diseases | Edward Chang, M.D.
1:53:25
1:53:25
Play later
Play later
Lists
Like
Liked
1:53:25View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Edward Chang is a neurosurgeon, scientist, and a pioneering leader in functional neurosurgery and brain-computer interface technology, whose work spans the operating room, the research lab, and the engineering bench to…
…
continue reading

1
NSTEMI: 📉 Less Ischemia, Less Reintervention
5:11
5:11
Play later
Play later
Lists
Like
Liked
5:11🚨 New Evidence in NSTEMI Care! 🫀 The SLIM Trial shows that FFR-guided complete revascularization during the index procedure in patients with NSTEMI and multivessel disease significantly reduces death, MI, stroke, and repeat PCI compared to culprit-only PCI. 🎯 Key win? Fewer revascularizations, better outcomes — physiology beats anatomy again. 📚 Pub…
…
continue reading

1
Yu Mi Kang on the PCSK9 inhibitor Evolocumab & the FOURIER Trial, Neda Rasouli with insights on semaglutide in symptomatic peripheral artery disease & the STRIDE Trial, and more!
42:09
42:09
Play later
Play later
Lists
Like
Liked
42:09Welcome to episode no. 35 (September 2025) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the September 2025 issue of Diabetes Care and beyond. 3:05 Alice is joined by Yu …
…
continue reading

1
Real-World Rx 💊, Real Results 📉: GLP-1 Agents Slash HFpEF Risk
6:04
6:04
Play later
Play later
Lists
Like
Liked
6:04💥 Practice-Changing Evidence in HFpEF! 💥 In a real-world cohort of 97,000+ patients with obesity & type 2 diabetes, semaglutide and tirzepatide reduced risk of heart failure hospitalization or death by over 40% 📉 ⚖️ No meaningful difference between the two agents. 🧠 Findings reinforce STEP-HFpEF & SUMMIT trials and highlight GLP-1 therapies’ expand…
…
continue reading

1
Novel strategies and advances in the management and classification of MDS: insights from iwMDS 2025
17:00
17:00
Play later
Play later
Lists
Like
Liked
17:00This episode features discussions from the 3rd International Workshop on Myelodysplastic Syndromes & Myeloproliferative Neoplasms (iwMDS & iwMPN) 2025, held in Lisbon, Portugal. First, you will hear from Uma Borate, MD, The Ohio State University, Columbus, OH, Luca Lanino, MD, PhD, Yale University, New Haven, CT, Robert Hasserjian, MD, Massachusett…
…
continue reading

1
The AMALFI AF Screening Trial-📈 Atrial Fibrillation Unmasked: A Modest Win for Mailed Monitors
3:20
3:20
Play later
Play later
Lists
Like
Liked
3:20📢 Just read the #AMALFI trial in JAMA 📰 — a landmark remote RCT of AF screening using 14-day ECG patches mailed to older adults at stroke risk 📦🫀. At 2.5 years, the patch group had a modestly higher AF detection rate (6.8% vs 5.4%, p=0.03) and increased anticoagulation use 💊🧠. Stroke rates were similar ⚖️. 🎯 Key takeaway: Remote, mail-based AF scre…
…
continue reading

1
🛑 AFib Gone, OAC Gone? ALONE-AF Challenges Lifelong Therapy
5:14
5:14
Play later
Play later
Lists
Like
Liked
5:14🚨 New Trial Alert 🚨 Can we safely stop anticoagulation after AF ablation? The ALONE-AF Trial 🫀 suggests yes—in selected patients with no AF recurrence, stopping DOACs reduced major bleeding 🌟 without increasing stroke risk 🧠. 📉 0.3% vs 2.2% for the composite outcome (P = .02) 📍 Carefully monitored, low-risk patients may benefit most. 📝 Editorial: R…
…
continue reading

1
Part 1: Managing the Complexity of NewYork-Presbyterian’s High Volume Emergency Departments
15:12
15:12
Play later
Play later
Lists
Like
Liked
15:12On this episode of Advances in Care, host Erin Welsh hears from two emergency department chiefs at NewYork-Presbyterian about how they optimize operations in their uniquely high-intensity, high-volume EDs. Dr. Angela Mills, chief of emergency medicine at NewYork-Presbyterian and Columbia, and Dr. Brenna Farmer, chief of emergency medicine at NewYor…
…
continue reading

1
🦠💔Bugged After the Heartbreak? Does H. pylori Screening After MI Prevent GI Bleeds?
5:16
5:16
Play later
Play later
Lists
Like
Liked
5:16🚨 New Findings from the HELP-MI Trial! 🇸🇪🧪 Can routine Helicobacter pylori screening during acute myocardial infarction (MI) hospitalization prevent upper gastrointestinal bleeding (UGIB)? 💉 Over 18,000 patients across 35 Swedish hospitals 📉 Result: No significant reduction in UGIB overall (RR 0.90; P=0.18) 🔍 BUT: Clear benefit in patients with ane…
…
continue reading

1
One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine
1:20:08
1:20:08
Play later
Play later
Lists
Like
Liked
1:20:08For decades, psychiatry has relied on treatments that are slow and often ineffective. But what if one intervention could reset the brain, break the grip of addiction, and open the door to an entirely new model of care? On this episode of The Dr. Hyman Show, I sit down with Dr. Nolan Williams, a Stanford neuropsychiatrist pioneering new therapies fo…
…
continue reading

1
Evidence and Ethics in Healthcare Research with Dr. Zeke Emanuel Part 2 Ep 330
28:07
28:07
Play later
Play later
Lists
Like
Liked
28:07Send us a text The conversation between Dr. Michael Koren and Dr. Zeke Emanuel continues in part 2. Bioethicist Zeke Emanuel dives into the unethical Tuskeegee study and landmark Belmont Report in 1979 and how many safeguards to clinical research are currently in effect. They doctoral duo also talk about how in spite of the potentially off-putting …
…
continue reading

1
Progress in Lipoprotein(a) Makes a Big Splash at the European Society of Cardiology Ep. 329
4:03
4:03
Play later
Play later
Lists
Like
Liked
4:03Send us a text Dr. Michael Koren joins Kevin Geddings to report live from Madrid on new developments being presented at the European Society of Cardiology meeting. This medical gathering, now the world's largest, is a showcase of developments in heart health and medicine. Dr. Koren notes excitement about progress in treating a genetic condition, li…
…
continue reading

1
🧬 Risk, Recurrence, Relief: Apixaban’s Edge in VTE 🌡️ Emphasizes the risk stratification, recurrence data, and therapeutic benefit
3:33
3:33
Play later
Play later
Lists
Like
Liked
3:33🩺 New Insights on Apixaban for VTE! 📢 The HI-PRO trial challenges the old 3-month rule for provoked VTE. 📉 Extended low-dose apixaban (2.5 mg BID) reduced recurrent VTE from 10.0% ➡️ 1.3% with minimal major bleeding. 🎯 Editorial in NEJM urges a shift from binary labels (“provoked vs unprovoked”) to a patient-centered, risk-adapted approach. 🧠 Art m…
…
continue reading

1
Multi-Arterial and Total Arterial Bypass Grafting
14:23
14:23
Play later
Play later
Lists
Like
Liked
14:23Faisal Bakaeen, MD, and Donna Kimmaliardjuk, MD, discuss the benefits and considerations of multi-arterial coronary artery bypass grafting (CABG), a technique that can improve long-term outcomes for patients with coronary artery disease. They share insights on patient selection, surgical innovations, personalized care and optimal medical management…
…
continue reading

1
Dr RR Baliga's Philosophical Discourses: Zhu Xi (China, 1130–1200 CE) – Neo-Confucian Philosopher
4:04
4:04
Play later
Play later
Lists
Like
Liked
4:04🌏 Zhu Xi (1130–1200), a master of Neo-Confucianism, reshaped Chinese philosophy with his focus on rationality, self-cultivation & education. His commentaries on the Four Books guided civil service exams for centuries across East Asia. 📚✨ #Leadership #Philosophy #History #ConfucianismBy MasterMedFacts LLC
…
continue reading

1
Gait Speed. Grip Strength. Greater Life. 🦵🤝🌟 A Paradigm Shift in Cardiovascular Recovery for Seniors
5:23
5:23
Play later
Play later
Lists
Like
Liked
5:23Just read the latest from NEJM? The PIpELINe Trial 🇮🇹 changes how we approach cardiac rehab in older adults post-MI! 🧓❤️ 🎯 A 12-month, multidomain intervention — risk factor control, nutrition 🥗, and Otago-based exercise 👟 — cut CV death/hospitalization from 20.6% → 12.6% (P=0.01)! 📉 Hospitalizations for heart failure dropped 7.1% → 1.5%. No seriou…
…
continue reading

1
S1 Ep177: Man Up? The Truth About Men's Health After Cancer
40:08
40:08
Play later
Play later
Lists
Like
Liked
40:08In a recent episode of the Oncology-on-the-Go podcast in collaboration with the American Psychosocial Oncology Society (APOS), host Daniel C. McFarland, DO, was joined by Christian J. Nelson, PhD, to discuss the often-overlooked subject of sexual health issues for men after cancer treatment. The discussion emphasized the importance of a nuanced app…
…
continue reading

1
The Nutrient Blueprint for a Longer, Healthier Life
59:31
59:31
Play later
Play later
Lists
Like
Liked
59:31Nutrients are far more than supplements on a shelf—they are life-sustaining molecules that determine how well the body ages and resists disease. For years, their importance was overlooked because many studies were poorly designed, failing to consider existing nutrient levels or how vitamins and minerals work together. Strong evidence now shows mult…
…
continue reading

1
💊 Block. Beat. Benefit. The Hidden Strength of β-Blockers Post-MI
4:03
4:03
Play later
Play later
Lists
Like
Liked
4:03🚨 New Meta-Analysis Alert! 💊🫀 Can β-blockers benefit patients post-MI with mildly reduced ejection fraction (LVEF 40–49%)? 📊 An individual patient data meta-analysis (REBOOT, BETAMI, DANBLOCK, CAPITAL-RCT) shows a 25% reduction in the composite outcome of death, MI, or HF with β-blockers vs. control (HR 0.75; p=0.031) — even in the absence of clini…
…
continue reading

1
Lower back pain: causes, treatment, and prevention of lower back injuries and pain | Stuart McGill, Ph.D. (#287 rebroadcast)
2:31:22
2:31:22
Play later
Play later
Lists
Like
Liked
2:31:22View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Stuart McGill is a distinguished professor emeritus at the University of Waterloo and the chief scientific officer at Backfitpro where he specializes in evaluating complex cases of lower back pain from across the globe…
…
continue reading

1
🧠 REBOOTing Beta-Blockers – No Gains ⚖️ After Modern MI 💔
4:59
4:59
Play later
Play later
Lists
Like
Liked
4:59🚫💊 Should We Rethink Beta-Blockers Post-MI? In the landmark REBOOT trial (NEJM, 2025), beta-blockers failed to reduce mortality, reinfarction, or heart failure hospitalizations in post-MI patients with preserved ejection fraction (>40%). 💡 A modern, pragmatic trial across 109 centers (Spain + Italy 🇪🇸🇮🇹) with 8438 patients — shaking the foundation …
…
continue reading

1
Beta Blockers in MI: Old Drug, New Lens, Possible Win 🔍💥🏥
4:49
4:49
Play later
Play later
Lists
Like
Liked
4:49🚨 New NEJM Study Alert! 🩺💔 Do beta-blockers still help after a heart attack if there’s no heart failure? 🤔 In the BETAMI–DANBLOCK trial (🇩🇰+🇳🇴, n=5574), beta-blocker therapy in post-MI patients with preserved or mildly reduced LVEF (≥40%) modestly reduced the composite outcome of death or major cardiovascular events 🧠📉 📌 Primary endpoint: 14.2% (BB…
…
continue reading
💥 New NEJM Trial Alert! A modest 0.3 mmol/L rise in potassium (via MRA, KCl, or diet) significantly reduced arrhythmias, ICD shocks, and hospitalizations in high-risk ICD patients ⚡🫀 📉 HR 0.76 for the composite endpoint 🔢 NNT = 12.3 over 3.3 years 🍌 Safe, scalable, and globally relevant 👉 Time to rethink “normal” K⁺ levels in cardiology! #Cardiolog…
…
continue reading

1
🫀 Foxglove, Frailty, and HFrEF — Digitoxin in Advanced Heart Failure
6:01
6:01
Play later
Play later
Lists
Like
Liked
6:01🚨 New RCT Alert from the NEJM! Can an old 💊 make a comeback in modern 💓 failure care? 📌 The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy — including ARNI, beta-blockers, MRAs & SGLT…
…
continue reading

1
From Sclerosis 🧱 to Stenosis 🚪 to Surgery 🔧
10:04
10:04
Play later
Play later
Lists
Like
Liked
10:04🚨 Calcific Aortic Valve Stenosis (CAVS): Beyond Wear and Tear 🫀🪨 Once thought to be “degenerative,” CAVS is now recognized as an active disease driven by oxidative stress ⚡, inflammation 🔥, and lipoprotein(a) 🧬. Despite its growing global burden, no drug therapy slows its progression. 🩺 Current management: Surgical (SAVR) or Transcatheter (TAVR) va…
…
continue reading

1
💊📉 Mix, Match, and Lower: Predicting BP Drops with Drug Combos
4:44
4:44
Play later
Play later
Lists
Like
Liked
4:44🚨 New in The Lancet (2025) 🚨 A mega meta-analysis of 484 RCTs (104K+ participants) offers a game-changing approach to hypertension management! 💊📉 Instead of guessing how much BP will drop, now you can predict it—by drug, dose, and combo! 🎯 Like statins for LDL, this study introduces low-, moderate-, and high-intensity BP regimens based on expected …
…
continue reading

1
The Protean Manifestations of Obesity Ep. 328
35:19
35:19
Play later
Play later
Lists
Like
Liked
35:19Send us a text Proteus was a Greek sea god who could change his form, much like obesity is able to in the body. Doctors Michael Koren, Victoria Helow, and Michael Bernhardt come together in front of a live audience for a discussion on the myriad effects obesity has in and on the body. The doctors move through how excess weight affects the heart, sk…
…
continue reading

1
Partial Hearts. Whole Hope. Lasting Change. 🧩❤️🔬 A Bold Leap Forward in Pediatric Cardiac Surgery
4:43
4:43
Play later
Play later
Lists
Like
Liked
4:43🧒❤️ Partial Heart Transplant: A Growing Solution for Growing Hearts! 🌱🔬 🚨 Pediatric patients with congenital heart valve disease often face multiple surgeries due to non-living valve grafts that don’t grow. This landmark study from @DukeHealth shows how living valves via partial heart transplant can change the game. 📊 In 19 patients (median age: 97…
…
continue reading

1
🧬🔬 From Barnyard to Human Chest: 216 Hours of Pig Lung in Man
5:10
5:10
Play later
Play later
Lists
Like
Liked
5:10🐖🫁 World First: Pig Lung Transplanted into Human 🧬🌍 In a groundbreaking step for xenotransplantation, a team in China successfully transplanted a genetically modified pig lung into a brain-dead human recipient. The lung functioned for 216 hours without hyperacute rejection, offering hope to thousands on organ waitlists. 🔬 Key breakthroughs: • 6-gen…
…
continue reading

1
Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF
20:52
20:52
Play later
Play later
Lists
Like
Liked
20:52Interview with Margaret Infeld, MD, MS, author of Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction: Follow-Up of the myPACE Trial. Hosted by Robert Bonow, MD. Related Content: Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejectio…
…
continue reading